For the quarter ending 2026-03-31, ESLA has $3,657,198 in assets. $8,927,494 in debts.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 1,927,404 | 1,384,302 | 1,626,610 | 1,316,594 |
| Prepaid expenses and other receivables | 229,794 | 292,673 | 396,901 | 163,933 |
| Total current assets | 2,157,198 | 1,676,975 | 2,023,511 | 1,480,527 |
| Prepaid expenses, related party , non-current-Related Party | - | - | 1,500,000 | 1,500,000 |
| Prepaid expenses, related party , non-current | - | 1,500,000 | - | - |
| Prepaid expenses, related party, non-current | 1,500,000 | - | - | - |
| Total assets | 3,657,198 | 3,176,975 | 3,523,511 | 2,980,527 |
| Accounts payable - related party | 14,947 | 554,781 | 5,631 | 8,154 |
| Other payables and accrued liabilities | 179,082 | 238,414 | 75,615 | 110,767 |
| Income tax payables | - | - | - | 0 |
| Accrued liability - related party | 8,268,333 | 12,393,333 | 12,893,333 | 8,768,333 |
| Franchise tax payable | - | - | - | 0 |
| Derivative liabilities | 465,132 | 356,505 | 385,355 | 187,941 |
| Preferred stock, value-Series APreferred Stock | - | - | - | 0 |
| Total current liabilities | 8,927,494 | 13,543,033 | 13,359,934 | 9,075,195 |
| Preferred stock, value-Series AAPreferred Stock | - | - | - | 0 |
| Total liabilities | 8,927,494 | 13,543,033 | 13,359,934 | 9,075,195 |
| Common stock, 0.0001 par value 250,000,000 shares authorized 43,180,509 and 38,486,219 shares issued as of march 31, 2026 and december 31, 2025, respectively | 4,318 | 3,849 | 3,828 | 3,758 |
| Additional paid-in capital | 34,606,644 | 27,219,287 | 27,135,769 | 26,076,445 |
| Accumulated deficit | -39,282,879 | -36,990,815 | -36,377,641 | -31,576,492 |
| Treasury stock, at cost 515,281 shares as of march 31, 2026 and december 31, 2025 | 598,379 | 598,379 | 598,379 | 598,379 |
| Total stockholders deficit | -5,270,296 | -10,366,058 | -9,836,423 | -6,094,668 |
| Total liabilities and stockholders deficit | 3,657,198 | 3,176,975 | 3,523,511 | 2,980,527 |
Estrella Immunopharma, Inc. (ESLA)
Estrella Immunopharma, Inc. (ESLA)